December 16, 2022
Article
Several factors predict itch-specific quality of life in patients with chronic itch.
November 21, 2022
This is the first FDA-approved ADC for platinum-resistant disease, according to ImmunoGen.
October 18, 2022
History of migraine may be associated with poor sleep in premenopausal and perimenopausal women, according to research presented at the North American Menopause Society Annual Meeting.
August 10, 2022
The FDA has granted Emergency Use Authorization EUA of the Jynneos vaccine for pediatric patients
August 09, 2022
Myovant Sciences and Pfizer announces the FDA has approved the therapy for the once-daily treatment of moderate-to-severe endometriosis-associated pain.
July 11, 2022
Perrigo’s HRA Pharma has submitted an application to the FDA for possible future approval of the first-ever OTC birth control pill.